The Orange Book Transparency Act of 2020 (H.R. 1503) was signed into law last January 5, 2021. The Act updates regulations of the US Food and Drug Administration concerning the Approved Drug Products with Therapeutic Equivalence Evaluations (more commonly known as the Orange Book) which contains publicly available patent and...
An interesting corner of the growing world of AI is its adoption in the automotive industry. As automakers are racing to develop driverless vehicles for widespread adoption, they recognize that leveraging AI-powered solutions and features will be the key differentiators for their brand....
Along with a $900-billion COVID-19 relief package and the $1.4 trillion government funding for pandemic aid, the FY 2021 Omnibus Appropriations Bill, signed December 27, 2020, also includes two acts and two amendments relevant to intellectual property (IP) law. CASE Act The ‘‘Copyright Alternative in Small-Claims Enforcement Act of 2020’’ or...
Just weeks after Pfizer and Moderna unveil successful clinical trials for their COVID-19 vaccine candidates, a third pharmaceutical giant makes headway with its potential answer to the pandemic. On November 23, Britain’s AstraZeneca published interim trial results for AZD1222, a vaccine it co-developed with the University of Oxford....
UK regulator Medicines and Healthcare Products Regulatory Authority (MHRA) has given emergency approval to Pfizer and BioNTech’s vaccine on December 2, making the UK the first country to approve a COVID-19 vaccine for widespread use....
On November 16, Moderna claimed the latest breakthrough with its vaccine candidate mRNA-1237, deemed 94.5% effective against COVID-19 — just within striking distance of Pfizer’s vaccine, which demonstrated 95% efficacy according to the pharma giant....